Report cover image

Global Organoids and Spheroids Market 2025 – 2034

Publisher Custom Market Insights
Published Nov 01, 2025
SKU # CSTM20669765

Description

Organoids and Spheroids Market Size, Trends and Insights By Organoids Type (Neural Organoids, Hepatic Organoids, Intestinal Organoids, Other Organoids), By Spheroids Type (Multicellular Tumor Spheroids (MCTS), Neurospheres, Mammospheres, Hepatospheres, Embryoid Bodies), By Organoids Source (Primary Tissues, Stem Cells), By Spheroids Source (Cell Line, Primary Cell, iPSCs Derived Cells), By End User (BioSource and Pharmaceutical Industries, Academic & Research Institutes, Hospitals and Diagnostic Centers), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034

Table of Contents

Chapter 1. Preface
1.1 Report Description and Scope
1.2 Research scope
1.3 Research methodology
1.3.1 Market Research Type
1.3.2 Market research methodology
Chapter 2. Executive Summary
2.1 Global Organoids and Spheroids Market, (2025 – 2034) (USD Million)
2.2 Global Organoids and Spheroids Market : snapshot
Chapter 3. Global Organoids and Spheroids Market – Industry Analysis
3.1 Organoids and Spheroids Market: Market Dynamics
3.2 Market Drivers
3.2.1 Advancements in Disease Modelling and Drug Discovery
3.2.2 Technological Innovations Enhancing 3D Cell Culture Efficiency
3.3 Market Restraints
3.4 Market Opportunities
3.5 Market Challenges
3.6 Porters Five Forces Analysis
3.7 Market Attractiveness Analysis
3.7.1 Market attractiveness analysis By Organoids Type
3.7.2 Market attractiveness analysis By Spheroids Type
3.7.3 Market attractiveness analysis By Organoids Source
3.7.4 Market attractiveness analysis By Spheroids Source
3.7.5 Market attractiveness analysis By End User
Chapter 4. Global Organoids and Spheroids Market- Competitive Landscape
4.1 Company market share analysis
4.1.1 Global Organoids and Spheroids Market: company market share, 2024
4.2 Strategic development
4.2.1 Acquisitions & mergers
4.2.2 New Product launches
4.2.3 Agreements, partnerships, cullaborations, and joint ventures
4.2.4 Research and development and Regional expansion
4.3 Price trend analysis
Chapter 5. Global Organoids and Spheroids Market – Organoids Type Analysis
5.1 Global Organoids and Spheroids Market overview: By Organoids Type
5.1.1 Global Organoids and Spheroids Market share, By Organoids Type, 2024 and 2034
5.2 Neural Organoids
5.2.1 Global Organoids and Spheroids Market by Neural Organoids, 2025 – 2034 (USD Million)
5.3 Hepatic Organoids
5.3.1 Global Organoids and Spheroids Market by Hepatic Organoids, 2025 – 2034 (USD Million)
5.4 Intestinal Organoids
5.4.1 Global Organoids and Spheroids Market by Intestinal Organoids, 2025 – 2034 (USD Million)
5.5 Other Organoids
5.5.1 Global Organoids and Spheroids Market by Other Organoids, 2025 – 2034 (USD Million)
Chapter 6. Global Organoids and Spheroids Market – Spheroids Type Analysis
6.1 Global Organoids and Spheroids Market overview: By Spheroids Type
6.1.1 Global Organoids and Spheroids Market share, By Spheroids Type, 2024 and 2034
6.2 Multicellular Tumor Spheroids (MCTS)
6.2.1 Global Organoids and Spheroids Market by Multicellular Tumor Spheroids (MCTS), 2025 – 2034 (USD Million)
6.3 Neurospheres
6.3.1 Global Organoids and Spheroids Market by Neurospheres, 2025 – 2034 (USD Million)
6.4 Mammospheres
6.4.1 Global Organoids and Spheroids Market by Mammospheres, 2025 – 2034 (USD Million)
6.5 Hepatospheres
6.5.1 Global Organoids and Spheroids Market by Hepatospheres, 2025 – 2034 (USD Million)
6.6 Embryoid Bodies
6.6.1 Global Organoids and Spheroids Market by Embryoid Bodies, 2025 – 2034 (USD Million)
Chapter 7. Global Organoids and Spheroids Market – Organoids Source Analysis
7.1 Global Organoids and Spheroids Market overview: By Organoids Source
7.1.1 Global Organoids and Spheroids Market share, By Organoids Source, 2024 and 2034
7.2 Primary Tissues
7.2.1 Global Organoids and Spheroids Market by Primary Tissues, 2025 – 2034 (USD Million)
7.3 Stem Cells
7.3.1 Global Organoids and Spheroids Market by Stem Cells, 2025 – 2034 (USD Million)
Chapter 8. Global Organoids and Spheroids Market – Spheroids Source Analysis
8.1 Global Organoids and Spheroids Market overview: By Spheroids Source
8.1.1 Global Organoids and Spheroids Market share, By Spheroids Source, 2024 and 2034
8.2 Cell Line
8.2.1 Global Organoids and Spheroids Market by Cell Line, 2025 – 2034 (USD Million)
8.3 Primary Cell
8.3.1 Global Organoids and Spheroids Market by Primary Cell, 2025 – 2034 (USD Million)
8.4 iPSCs Derived Cells
8.4.1 Global Organoids and Spheroids Market by iPSCs Derived Cells, 2025 – 2034 (USD Million)
Chapter 9. Global Organoids and Spheroids Market – End User Analysis
9.1 Global Organoids and Spheroids Market overview: By End User
9.1.1 Global Organoids and Spheroids Market share, By End User, 2024 and 2034
9.2 BioSource and Pharmaceutical Industries
9.2.1 Global Organoids and Spheroids Market by BioSource and Pharmaceutical Industries, 2025 – 2034 (USD Million)
9.3 Academic & Research Institutes
9.3.1 Global Organoids and Spheroids Market by Academic & Research Institutes, 2025 – 2034 (USD Million)
9.4 Hospitals and Diagnostic Centers
9.4.1 Global Organoids and Spheroids Market by Hospitals and Diagnostic Centers, 2025 – 2034 (USD Million)
Chapter 10. Organoids and Spheroids Market – Regional Analysis
10.1 Global Organoids and Spheroids Market Regional Overview
10.2 Global Organoids and Spheroids Market Share, by Region, 2024 & 2034 (USD Million)
10.3. North America
10.3.1 North America Organoids and Spheroids Market, 2025 – 2034 (USD Million)
10.3.1.1 North America Organoids and Spheroids Market, by Country, 2025 – 2034 (USD Million)
10.4 North America Organoids and Spheroids Market, by Organoids Type, 2025 – 2034
10.4.1 North America Organoids and Spheroids Market, by Organoids Type, 2025 – 2034 (USD Million)
10.5 North America Organoids and Spheroids Market, by Spheroids Type, 2025 – 2034
10.5.1 North America Organoids and Spheroids Market, by Spheroids Type, 2025 – 2034 (USD Million)
10.6 North America Organoids and Spheroids Market, by Organoids Source, 2025 – 2034
10.6.1 North America Organoids and Spheroids Market, by Organoids Source, 2025 – 2034 (USD Million)
10.7 North America Organoids and Spheroids Market, by Spheroids Source, 2025 – 2034
10.7.1 North America Organoids and Spheroids Market, by Spheroids Source, 2025 – 2034 (USD Million)
10.8 North America Organoids and Spheroids Market, by End User, 2025 – 2034
10.8.1 North America Organoids and Spheroids Market, by End User, 2025 – 2034 (USD Million)
10.9. Europe
10.9.1 Europe Organoids and Spheroids Market, 2025 – 2034 (USD Million)
10.9.1.1 Europe Organoids and Spheroids Market, by Country, 2025 – 2034 (USD Million)
10.10 Europe Organoids and Spheroids Market, by Organoids Type, 2025 – 2034
10.10.1 Europe Organoids and Spheroids Market, by Organoids Type, 2025 – 2034 (USD Million)
10.11 Europe Organoids and Spheroids Market, by Spheroids Type, 2025 – 2034
10.11.1 Europe Organoids and Spheroids Market, by Spheroids Type, 2025 – 2034 (USD Million)
10.12 Europe Organoids and Spheroids Market, by Organoids Source, 2025 – 2034
10.12.1 Europe Organoids and Spheroids Market, by Organoids Source, 2025 – 2034 (USD Million)
10.13 Europe Organoids and Spheroids Market, by Spheroids Source, 2025 – 2034
10.13.1 Europe Organoids and Spheroids Market, by Spheroids Source, 2025 – 2034 (USD Million)
10.14 Europe Organoids and Spheroids Market, by End User, 2025 – 2034
10.14.1 Europe Organoids and Spheroids Market, by End User, 2025 – 2034 (USD Million)
10.15. Asia Pacific
10.15.1 Asia Pacific Organoids and Spheroids Market, 2025 – 2034 (USD Million)
10.15.1.1 Asia Pacific Organoids and Spheroids Market, by Country, 2025 – 2034 (USD Million)
10.16 Asia Pacific Organoids and Spheroids Market, by Organoids Type, 2025 – 2034
10.16.1 Asia Pacific Organoids and Spheroids Market, by Organoids Type, 2025 – 2034 (USD Million)
10.17 Asia Pacific Organoids and Spheroids Market, by Spheroids Type, 2025 – 2034
10.17.1 Asia Pacific Organoids and Spheroids Market, by Spheroids Type, 2025 – 2034 (USD Million)
10.18 Asia Pacific Organoids and Spheroids Market, by Organoids Source, 2025 – 2034
10.18.1 Asia Pacific Organoids and Spheroids Market, by Organoids Source, 2025 – 2034 (USD Million)
10.19 Asia Pacific Organoids and Spheroids Market, by Spheroids Source, 2025 – 2034
10.19.1 Asia Pacific Organoids and Spheroids Market, by Spheroids Source, 2025 – 2034 (USD Million)
10.20 Asia Pacific Organoids and Spheroids Market, by End User, 2025 – 2034
10.20.1 Asia Pacific Organoids and Spheroids Market, by End User, 2025 – 2034 (USD Million)
10.21. Latin America
10.21.1 Latin America Organoids and Spheroids Market, 2025 – 2034 (USD Million)
10.21.1.1 Latin America Organoids and Spheroids Market, by Country, 2025 – 2034 (USD Million)
10.22 Latin America Organoids and Spheroids Market, by Organoids Type, 2025 – 2034
10.22.1 Latin America Organoids and Spheroids Market, by Organoids Type, 2025 – 2034 (USD Million)
10.23 Latin America Organoids and Spheroids Market, by Spheroids Type, 2025 – 2034
10.23.1 Latin America Organoids and Spheroids Market, by Spheroids Type, 2025 – 2034 (USD Million)
10.24 Latin America Organoids and Spheroids Market, by Organoids Source, 2025 – 2034
10.24.1 Latin America Organoids and Spheroids Market, by Organoids Source, 2025 – 2034 (USD Million)
10.25 Latin America Organoids and Spheroids Market, by Spheroids Source, 2025 – 2034
10.25.1 Latin America Organoids and Spheroids Market, by Spheroids Source, 2025 – 2034 (USD Million)
10.26 Latin America Organoids and Spheroids Market, by End User, 2025 – 2034
10.26.1 Latin America Organoids and Spheroids Market, by End User, 2025 – 2034 (USD Million)
10.27. The Middle-East and Africa
10.27.1 The Middle-East and Africa Organoids and Spheroids Market, 2025 – 2034 (USD Million)
10.27.1.1 The Middle-East and Africa Organoids and Spheroids Market, by Country, 2025 – 2034 (USD Million)
10.28 The Middle-East and Africa Organoids and Spheroids Market, by Organoids Type, 2025 – 2034
10.28.1 The Middle-East and Africa Organoids and Spheroids Market, by Organoids Type, 2025 – 2034 (USD Million)
10.29 The Middle-East and Africa Organoids and Spheroids Market, by Spheroids Type, 2025 – 2034
10.29.1 The Middle-East and Africa Organoids and Spheroids Market, by Spheroids Type, 2025 – 2034 (USD Million)
10.30 The Middle-East and Africa Organoids and Spheroids Market, by Organoids Source, 2025 – 2034
10.30.1 The Middle-East and Africa Organoids and Spheroids Market, by Organoids Source, 2025 – 2034 (USD Million)
10.31 The Middle-East and Africa Organoids and Spheroids Market, by Spheroids Source, 2025 – 2034
10.31.1 The Middle-East and Africa Organoids and Spheroids Market, by Spheroids Source, 2025 – 2034 (USD Million)
10.32 The Middle-East and Africa Organoids and Spheroids Market, by End User, 2025 – 2034
10.32.1 The Middle-East and Africa Organoids and Spheroids Market, by End User, 2025 – 2034 (USD Million)
Chapter 11. Company Profiles
11.1 3D Biomatrix
11.1.1 Overview
11.1.2 Financials
11.1.3 Product Portfolio
11.1.4 Business Strategy
11.1.5 Recent Developments
11.2 3D Biotek LLC
11.2.1 Overview
11.2.2 Financials
11.2.3 Product Portfolio
11.2.4 Business Strategy
11.2.5 Recent Developments
11.3 AMS BioSource (Europe) Limited
11.3.1 Overview
11.3.2 Financials
11.3.3 Product Portfolio
11.3.4 Business Strategy
11.3.5 Recent Developments
11.4 Cellesce Ltd.
11.4.1 Overview
11.4.2 Financials
11.4.3 Product Portfolio
11.4.4 Business Strategy
11.4.5 Recent Developments
11.5 Corning Incorporated
11.5.1 Overview
11.5.2 Financials
11.5.3 Product Portfolio
11.5.4 Business Strategy
11.5.5 Recent Developments
11.6 Greiner Bio-One
11.6.1 Overview
11.6.2 Financials
11.6.3 Product Portfolio
11.6.4 Business Strategy
11.6.5 Recent Developments
11.7 Hubrecht Organoid Source (HUB)
11.7.1 Overview
11.7.2 Financials
11.7.3 Product Portfolio
11.7.4 Business Strategy
11.7.5 Recent Developments
11.8 InSphero
11.8.1 Overview
11.8.2 Financials
11.8.3 Product Portfolio
11.8.4 Business Strategy
11.8.5 Recent Developments
11.9 Lonza
11.9.1 Overview
11.9.2 Financials
11.9.3 Product Portfolio
11.9.4 Business Strategy
11.9.5 Recent Developments
11.10 Merck KGaA
11.10.1 Overview
11.10.2 Financials
11.10.3 Product Portfolio
11.10.4 Business Strategy
11.10.5 Recent Developments
11.11 Prellis Biologics
11.11.1 Overview
11.11.2 Financials
11.11.3 Product Portfolio
11.11.4 Business Strategy
11.11.5 Recent Developments
11.12 STEMCELL Technologies Inc.
11.12.1 Overview
11.12.2 Financials
11.12.3 Product Portfolio
11.12.4 Business Strategy
11.12.5 Recent Developments
11.13 Thermo Fisher Scientific Inc.
11.13.1 Overview
11.13.2 Financials
11.13.3 Product Portfolio
11.13.4 Business Strategy
11.13.5 Recent Developments
11.14 Others.
11.14.1 Overview
11.14.2 Financials
11.14.3 Product Portfolio
11.14.4 Business Strategy
11.14.5 Recent Developments

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us